Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest

K H Kuck1, K P Kunze, M Schlüter

  • 1Department of Cardiology, University Hospital Eppendorf, Hamburg, Federal Republic of Germany.

European Heart Journal
|February 1, 1988
PubMed

Insights

Programmed electrical stimulation can induce dangerous ventricular arrhythmias in both symptomatic and asymptomatic patients with hypertrophic cardiomyopathy. This testing helps identify individuals at risk for sudden cardiac events.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart condition associated with ventricular arrhythmias.
  • Identifying patients at risk for sudden cardiac death remains a clinical challenge.

Purpose of the Study:

  • To evaluate the efficacy of programmed electrical stimulation (PES) in inducing ventricular arrhythmias in symptomatic and asymptomatic HCM patients.
  • To determine if PES can identify HCM patients at risk for life-threatening arrhythmias.

Main Methods:

  • PES was performed in 54 HCM patients, categorized as symptomatic (n=11) or asymptomatic (n=43).
  • Atrial and ventricular stimulation protocols were used to induce arrhythmias.
  • Induced arrhythmias were classified by type and duration.

Main Results:

  • Ventricular arrhythmias were induced in 18 patients (33%).
  • The incidence and type of induced arrhythmias did not significantly differ between symptomatic and asymptomatic groups (19% in asymptomatic).
  • Rapid polymorphic ventricular tachycardia or ventricular fibrillation were the most common induced arrhythmias.

Conclusions:

  • PES is effective in inducing ventricular arrhythmias in HCM patients, including those without prior symptoms.
  • Atrial stimulation-induced rapid ventricular tachycardia may identify HCM patients at high risk for exercise-induced ventricular fibrillation.

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...